|
|
Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.
Candice Trocmé
,
Hubert Marotte
,
Athan Baillet
,
Béatrice Pallot-Prades
,
Jérome Garin
,
et al.
Journal articles
inserm-00382264v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases.
Athan Baillet
,
Candice Trocmé
,
Sylvie Berthier
,
Marie Arlotto
,
Laurent Grange
,
et al.
Journal articles
inserm-00527450v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
Yves-Marie Pers
,
Clémentine Fortunet
,
Constant Elodie
,
Joseph Lambert
,
Marie Godfrin-Valnet
,
et al.
Journal articles
hal-03108989v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Is interleukin-6 an appropriate target to treat spondyloarthritis patients refractory to anti-tnf therapy? A cross-sectional national survey.
Fernando Kemta Lekpa
,
Cécile Poulain
,
Daniel Wendling
,
Martin Soubrier
,
Michel de Bandt
,
et al.
Journal articles
inserm-00683604v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Recommandations pour l'évaluation et l'optimisation de l'adhésion aux traitements de fond médicamenteux des rhumatismes inflammatoires chroniques : un processus basé sur des revues de la littérature et un consensus d'experts
Gossec Laure
,
Anna Molto
,
Xavier Romand
,
Déborah Puyraimond-Zemmour
,
Matthieu Lavielle
,
et al.
Journal articles
hal-02267417v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|